Suppression of Th1 and Th2 Immune Responses in Mice by Sinomenine, an Alkaloid Extracted from the Chinese Medicinal Plant Sinomenium acutum

Abstract

The present study was designed to investigate the effect of sinomenine (SIN), an alkaloid extracted from Sinomenium acutum, on Th1 and Th2 immune responses in mice. For this investigation, mice were s. c. immunized with ovalbumin (OVA) emulsified with complete Freund's adjuvant (day 0). Varying doses of SIN were orally administered daily over a period of 21 days, commencing on day 0. On day 21, anti-OVA IgG and proliferative responses of spleen cells to the antigen were measured. Anti-OVA IgG2a and IFN-γ were measured as indicators of Th1 immune responses and anti-OVA IgG1, IgE, and IL-5 as those of Th2 responses. TGF-β was measured as an indicator of Th3 immune responses. The results showed that treatment with SIN was followed by decreases in anti-OVA IgG and the antigen-specific splenocyte proliferation. Production of all isotypes of antibodies including anti-OVA IgG2a, IgG1 and IgE as well as secretion of cytokines such as IFN-γ and IL-5 was suppressed by SIN, although the suppression of anti-OVA IgG2a and IFN-γ by the alkaloid appeared to be greater than that of anti-OVA IgG1, IgE, and IL-5. In addition, SIN enhanced the secretion of TGF-β. These results suggest that SIN appears to have suppressive effects on both Th1 and Th2 immune responses. The results also suggest that Th1 responses may be more preferentially suppressed by the Sinomenium acutum-derived alkaloid compared to Th2 responses. TGF-β may at least in part contribute to the suppression of Th1 as well as Th2 immune responses.

Sinomenine - Th1 - Th2 - cytokines

References

• 1 Yoshino S, Yamaki K, Yanagisawa R, Takano H, Hayashi H, Mori Y. Effects of bisphenol A on antigen-specific antibody production, proliferative responses of lymphoid cells, and TH1 and TH2 immune responses in mice.  Br J Pharmacol. 2003;  138 1271-6
• 2 Yamaki K, Uchida H, Harada Y, Yanagisawa R, Takano H, Hayashi H. et al . Effect of the nonsteroidal anti-inflammatory drug indomethacin on Th1 and Th2 immune responses in mice.  J Pharm Sci. 2003;  92 1723-9
• 3 Skurkovich B, Skurkovich S. Anti-interferon-gamma antibodies in the treatment of autoimmune diseases.  . 2003;  5 52-7
• 4 Colavita A M, Reinach A J, Peters S P. Contributing factors to the pathobiology of asthma. The Th1/Th2 paradigm.  . 2000;  21 263-77
• 5 Corry D B, Folkesson H G, Warnock M L, Erle D J, Matthay M A, Wiener-Kronish J P. et al . Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.  J Exp Med. 1996;  183 109-17
• 6 Dickensheets H L, venkataraman C, Schindler U, Donnelly R P. Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression.  Proc Natl Acad Sci USA. 1999;  96 10 800-5
• 7 van Roon J A, van Roy J L, Duits A, Lafeber F P, Bijlsma J W. Proinflammatory cytokine production and cartilage damage due to rheumatoid synovial T helper-1 activation is inhibited by interleukin-4.  Ann Rheum Dis. 1995;  54 836-40
• 8 Liu L, Resch K, Kaever V. Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenine. Int.  J Immunopharmacol. 1994;  16 685-91
• 9 Liu L, Buchner E, beitze D, Schmidt-Weber C B, Kaever V, Emmrich F. et al . Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine.  Int J Immunopharmacol. 1996;  18 529-43
• 10 Wang Y, Zhou L, Li R. Study progress in Sinomenium acutum (Thunb.) Rehd. et Wils.  Zhong Yao Cai. 2002;  25 209-11
• 11 Wang W J, Wang P X, Li X J. The effect of sinomenine on cyclooxygenase activity and the expression of COX-1 and COX-2 mRNA in human peripheral monocytes.  Zhongguo Zhong Yao Za Zhi. 2003;  28 352-5
• 12 Wang Y, fang Y, Huang W, Zhou X, Wang M, Zhong B. et al . Effect of sinomenine on cytokine expression of macrophages and synoviocytes in adjuvant arthritis rats.  J Ethnopharmacol. 205;  98 37-43
• 13 Hochreiter R, Ferreira F, Thalhamer J, Hammerl P. TH1-promoting DNA immunization against allergens modulates the ratio of IgG1/IgG2a but does not affect the anaphylactic potential of IgG1 antibodies: no evidence for the synthesis of nonanaphylactic IgG1.  J Allergy Clin Immunol. 2003;  112 579-84
• 14 Trujillo-Vargas C M, Mayer K D, Bickert T, Palmetshofer A, Grunewald S, Ramirez-Pineda J R. et al . Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.  Clin Exp Allergy. 205;  25 1003-13
• 15 Jin N, Deng D, Wang H M, Tong D C. Sinomenine alone or combined with chloroquine and Tripterygium wilfordii glycoside in treating rheumatoid arthritis.  Zhong Guo Xing Yao Yu Ling Chuag Za Zhi. 1999;  18 215-7
• 16 Liu J H, Li W D, Teng H L, Lin Z B. Immunopharmacological action of sinomenine, an alkaloid isolated from Sinomenium acutum, and its mechanism of action in treating rheumatoid arthritis.  Yao Xue Xue Bao. 2005;  40 127-31
• 17 Kabashima K, Honda T, Nunokawa Y, Miyachi Y. A new NF-kappaB inhibitor attenuates a TH1 type immune response in a murine model.  FEBS Lett. 2004;  578 36-40
• 18 Corn R A, Aronica M A, Zhang F, Tong Y, Stanley S A, Kim S R. et al . T cell-intrinsic requirement for NF-kappa B induction in postdifferentiation IFN-gamma production and clonal expansion in a Th1 response.  J Immunol. 2003;  171 1816-24
• 19 Agrawal A, Dillon S, Denning T L, Pulendran B. ERK1^-/- mice exhibit Th1 cell polarization and increased susceptibility to experimental autoimmune encephalomyelitis.  J Immunol. 2006;  176 5788-96
• 20 He X, Wang J, guo Z, Liu Q, Chen T, Wang X. et al . Requirement for ERK activation in sinomenine-induced apoptosis of macrophages.  Immunol Lett. 2005;  98 91-6
• 21 Roy S, Wang J, Gupta S, Charboneau R, Loh H H, Barke R A. Chronic morphine treatment differentiates T helper cells to Th2 effector cells by modulating transcription factors GATA 3 and T-bet.  J Neuroimmunol. 2004;  147 78-81
• 22 Sacerdote P, Manfredi B, Gaspani L, Panerai A E. The opioid antagonist naloxone induces a shift from type 2 to type 1 cytokine pattern in BALB/cJ mice.  Blood. 2000;  95 2031-6
• 23 Wang C Y, Mo Z X, Tu H H. Effect of sinomenine on morphine dependence in isolated guinea pig ileum.  Di Yi Jun Yi Da Xue Xue Bao. 2003;  23 329-31
• 24 Belostotskii A M, Goren Z, Gottlieb H E. N-inversion-associated conformational dynamics is unusually rapid in morphine alkaloids.  J Nat Prod. 2004;  67 1842-9
• 25 Chen Y, Li J, Zhang J, Zhao T, Zou L, Tang Y. et al . Sinomenine inhibits B7-H1 and B7-DC expression on human renal tubular epithelial cells.  Int Immunopharmacol. 2005;  5 1446-57
• 26 Shin T, Yoshimura K, Shin T, Crafton E B, Tsuchiya H, Housseau F. et al . In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses.  J Exp Med. 2005;  201 1531-41
• 27 Matsumoto K, Inoue H, Nakano T, Tsuda M, Yoshiura Y, Fukuyama S. et al . B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism.  J Immunol. 2004;  172 2530-41
• 28 Yoshinaga S K, Whoriskey J S, Khare S D, Sarmiento U, Guo J, Horan T. et al . T-cell co-stimulation through B7RP-1 and ICOS.  Nature. 1999;  402 827-32
• 29 Tsuda M, Matsumoto K, Inoue H, Matsumura M, Nakano T, Mori A. et al . Expression of B7-H1 and B7-DC on the airway epithelium is enhanced by double-stranded RNA.  Biochem Biophys Res Commun. 2005;  330 263-70
• 30 Liu Z Q, Chan K, Zhou H, Jiang Z H, Wong Y F, Xu H X. et al . The pharmacokinetics and tissue distribution of sinomenine in rats and its protein binding ability in vitro .  Life Sci. 2005;  77 3197-209
• 31 Taylor A, Verhagen J, Blaser K, Akdis M, Akdis C A. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells.  Immunology. 2006;  4 433-42
• 32 Yamaki K, Uchida H, Li X, Yanagisawa R, Takano H, Hayashi H. et al . Effect of varying types of anti-arthritic drugs on Th1 and Th2 immune responses in mice.  Int J Immunopathol Pharmacol. 2005;  18 133-44
• 33 Tu S, Hu Y, Lu F. Effect of sinomenine on IL-8, IL-6, IL-2 produced by peripheral blood mononuclear cells.  J Tongji Med Univ. 1999;  19 257-9
• 34 Yoshino S, Murata Y, Ohsawa M. Successful induction of adjuvant arthritis in mice by treatment with a monoclonal antibody against IL-4.  J Immunol. 1998;  161 6904-8